Erythropoietintherapyforrenauanaemia Treatment protocotErythropoietin isqiven subcutaneousty atadose
of25-50UkqthreetmesperweekTheblood pressure.haemoalobinandreticulocvtecountshoudbe
monitoredeverv 2weeks Failuretorespondmav suaqestundertvinacoexistentirondeficiencv. bleedina.
malignancy or infectionBeneftsErythropoietinhas been demonstratedtoimproveauality-of-Life scores,
exercisetolerance.sexuaufunctionandcoanitivefunctionwhen orescribedforrenauanaemiaindialvsis
oatientsRisksDisadvantaqesincudethecostandariseinblood pressureinupto30%ofoatients.particularlv
durinqthefrst6monthsThereisariseinperipherauvascularresistanceduetoadecrease in hypoxic
vasodilatationandanincreaseinbloodviscositv Encephalopathv isararecomplication whichresutsinftsand
transientcorticaubuindness
@1MIN NDOCRINE
